TGFB1 and cancer: In addition, TGF-β activates the EMT process through the non-Smad signaling pathways, including the Wnt/β-catenin and MEK/ERK signaling pathways in several cancer cells (Galliher et al., 2006; Medici et al., 2008; Chen et al., 2012).